Rene Sindlev - 08 Jun 2022 Form 4 Insider Report for Enochian Biosciences Inc (RENB)

Role
Director, 10%+ Owner
Signature
/s/ Rene Sindlev
Issuer symbol
RENB
Transactions as of
08 Jun 2022
Net transactions value
$0
Form type
4
Filing time
18 Jul 2022, 06:02:50 UTC
Previous filing
20 May 2022
Next filing
25 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RENB Common Stock Other -125,000 -100% 0 08 Jun 2022 By RS Arving ApS F1
transaction RENB Common Stock Other -128,493 -100% 0 08 Jun 2022 By RS Group ApS F2
holding RENB Common Stock 9,668,351 08 Jun 2022 By RS Bio ApS
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 18, 2022, the reporting person entered into a contract to purchase shares in a private transaction. Certain conditions of the transaction were never fulfilled, including delivery of the shares, and on June 8, 2022, the reporting person terminated that contract, resulting in a return to the reporting person of the cash paid.
F2 On May 18, 2022, the reporting person entered into a contract to accept shares of the Issuer to satisfy a debt owed to the reporting person. The shares were never delivered to the reporting person and as a result on June 8, 2022 the reporting person terminated the contract.